Simultaneous sequencing of genetic and epigenetic bases in DNA
- PMID: 36747096
- PMCID: PMC10567558
- DOI: 10.1038/s41587-022-01652-0
Simultaneous sequencing of genetic and epigenetic bases in DNA
Abstract
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology. Most DNA sequencing approaches address either genetics or epigenetics and thus capture incomplete information. Methods widely used to detect epigenetic DNA bases fail to capture common C-to-T mutations or distinguish 5-methylcytosine from 5-hydroxymethylcytosine. We present a single base-resolution sequencing methodology that sequences complete genetics and the two most common cytosine modifications in a single workflow. DNA is copied and bases are enzymatically converted. Coupled decoding of bases across the original and copy strand provides a phased digital readout. Methods are demonstrated on human genomic DNA and cell-free DNA from a blood sample of a patient with cancer. The approach is accurate, requires low DNA input and has a simple workflow and analysis pipeline. Simultaneous, phased reading of genetic and epigenetic bases provides a more complete picture of the information stored in genomes and has applications throughout biomedicine.
© 2023. The Author(s).
Conflict of interest statement
Competing interests: S.B. is a founder, adviser and shareholder of Cambridge Epigenetix and of Inflex. All the other authors are current or former employees and hold share options. Patents covering this work and the methodologies described in this manuscript have been filed by Cambridge Epigenetix (patent applicant), inventors are S.B., J.F., W.S.G., J.D.H., S.L., D.M., O.N., T.O., M.S., A.V., N.J.W., S.Y, H.R.B. and R.S.S.-B. The application numbers are WO2022023753A1 (published), US20220298551A1 (pending), US20220290215A1 (issued), EP4034676A1(pending) and EP4083231A1 (pending).
Figures




Comment in
-
Simultaneous sequencing of genome and epigenome.Nat Rev Genet. 2023 Apr;24(4):208. doi: 10.1038/s41576-023-00589-7. Nat Rev Genet. 2023. PMID: 36829055 No abstract available.
-
Combined sequencing of genomes and epigenomes.Nat Methods. 2023 Apr;20(4):482. doi: 10.1038/s41592-023-01856-5. Nat Methods. 2023. PMID: 37046016 No abstract available.
-
Speed reading the epigenome and genome.Nat Biotechnol. 2023 Oct;41(10):1392-1393. doi: 10.1038/s41587-023-01757-0. Nat Biotechnol. 2023. PMID: 37085619 No abstract available.
-
Deciphering the cancer genome and epigenome.Nat Rev Cancer. 2023 Aug;23(8):509. doi: 10.1038/s41568-023-00590-6. Nat Rev Cancer. 2023. PMID: 37286894 No abstract available.
References
-
- Mazid MA, et al. Rolling back human pluripotent stem cells to an eight-cell embryo-like stage. Nature. 2022;605:315–324. - PubMed
-
- Yokobayashi S, et al. Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells. Cell Rep. 2021;37:109909. - PubMed
-
- Nishizawa M, et al. Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity. Cell Stem Cell. 2016;19:341–354. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials